JEREMY HILL: Open Payments
NPI 1649326349 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 73 payments from 15 companies in 2025. Trend: 2023 $481 · 2024 $1,110 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $304 |
| GENZYME CORPORATION | 8 | $304 |
| ABBVIE INC. | 14 | $206 |
| Galderma Laboratories, L.P. | 4 | $180 |
| Janssen Biotech, Inc. | 12 | $171 |
| Incyte Corporation | 5 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $73 |
| Amgen Inc. | 2 | $51 |
| LEO Pharma Inc. | 2 | $44 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
Products named: DUPIXENT, COSENTYX, TREMFYA, SKYRIZI, NEMLUVIO, OPZELURA, ILUMYA, OTEZLA.
Industry payments across CA — which companies pay providers there.
